Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03441581 Completed - Clinical trials for Irritable Bowel Syndrome With Diarrhea

Eluxadoline Bile Acid Malabsorption (BAM) Study

Start date: February 23, 2018
Phase: Phase 4
Study type: Interventional

This study will evaluate the possibility of a differential effect of eluxadoline on altered bowel function in Irritable Bowel Syndrome with Diarrhea (IBS-D) participants with and without evidence of Bile Acid Malabsorption (BAM).

NCT ID: NCT03441425 Completed - Stress Clinical Trials

Impact of Unexpected Death in Simulation: Skill Retention, Stress and Emotions

Start date: November 10, 2014
Phase: N/A
Study type: Interventional

Some educational researchers deliberately induce stress upon learners to in order to enhance retention; this practice is controversial and its utility must be weighed against the negative emotional effects it may have on participants. In this study we investigate the effect of the unexpected death of a simulation mannequin on the retention of non-technical and technical crisis resource management skills and consider the emotional impact of this acute stressor.

NCT ID: NCT03441386 Completed - Clinical trials for Cognitive Function and Well-Being

Acute Physical Exercise Intensity on Adolescents Cognitive Function

APICA
Start date: January 15, 2015
Phase: N/A
Study type: Interventional

Cognitive function and psychological well-being are two variables related to academic performance. Several studies have shown that these variables are sensitive to acute physical exercise, but it is not known which doses of exercise are the most adaptive. To explore this issue, a quasi-experimental study was conducted with 35 adolescents from three physical education classes. Participants performed three sessions of physical education with different doses of exercise: no exercise, light/moderate exercise, and moderate/vigorous exercise, controlling intensities with accelerometers. All subjects completed the Stroop test (to measure cognitive inhibition) and well-being questionnaires of subjective vitality, positive affect and negative affect before and after each session.

NCT ID: NCT03441360 Completed - Ewing Sarcoma Clinical Trials

Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)

Start date: April 17, 2018
Phase: Phase 2
Study type: Interventional

This study will be conducted as an assessment of the safety and preliminary activity of eribulin mesylate in pediatric participants with relapsed/refractory rhabdomyosarcoma (RMS), non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), or Ewing sarcoma (EWS) to determine whether each cohort warrants further investigation.

NCT ID: NCT03441204 Completed - Clinical trials for Chronic Respiratory Failure With Hypoxia

REgistry-based Treatment Duration and Mortality in Long-term OXygen Therapy (REDOX)

REDOX
Start date: May 16, 2018
Phase: Phase 4
Study type: Interventional

Multicenter, phase IV, non-superiority, registry-based, randomized controlled trial. Patients starting long-term oxygen therapy (LTOT) are randomized between LTOT prescribed 24 h/day or 15 h/day using the Swedish Register for Respiratory Failure (Swedevox). Clinical follow-up and concurrent treatments are according to routine clinical practice. The main endpoints of mortality, hospitalizations, and incident disease are assessed using Swedish registry data, with expected complete follow-up. Patient-reported outcomes are assessed using a posted questionnaire at 3 and 12 months. The study is managed by the Uppsala Clinical Research Centre (UCR).

NCT ID: NCT03441178 Completed - Clinical trials for Colectomy; Gynecological; Thoracic

A Prospective, Multi-Center Evaluation of the ENSEAL X1 Large Jaw Tissue Sealer

Start date: March 13, 2018
Phase: N/A
Study type: Interventional

This prospective, single-arm, multi-center, evaluation will collect clinical data in a post-market setting. The three types of procedures studied will be colectomy, gynecological, and thoracic. Investigators will perform each procedure using the device in compliance with their standard surgical approach and the ENSEAL X1 instructions for use.

NCT ID: NCT03441009 Completed - Clinical trials for Autonomic Nervous System Imbalance

Metabolism and the Activity of the Autonomic Nervous System in Patients With Paroxystic Sympathetic Hyperactivity, PSH

MANS-PSH
Start date: January 2, 2016
Phase:
Study type: Observational

Adult patients suffering from acquired brain damage run the risk of developing PSH. This group of patients is admitted to our unit, the Neurointensive Stepdown Unit, at Silkeborg Regional Hospital for intensive care and early neurorehabilitation. After weaning from intensive carethey are transferred to Hammel NeuroCentre. Aim is to assess whether HRV-derived variables in the frequency domain mirror therapeutic and/or nursing and/or pharmacologic interventions. To the extent clinically available BRS and metabolism are included in the assessment.

NCT ID: NCT03440840 Completed - Clinical trials for HIV-related Mild Neurocognitive Disorder

Computer Training and Transcranial Direct Current Stimulation for Cognition in HIV

Start date: January 16, 2018
Phase: N/A
Study type: Interventional

This study investigates the effectiveness of computer-based cognitive training with or without transcranial direct current stimulation (tDCS) in improving the functioning of older individuals with HIV-related cognitive dysfunction.

NCT ID: NCT03440658 Completed - Clinical trials for Obstetrical Brachial Plexus Palsy

Deficits of Strength of the Rotator Muscles of the Shoulder in Children

ROTPOPB
Start date: July 1, 2018
Phase:
Study type: Observational

The purpose of this retrospective work is to study the consequences of obstetrical brachial plexus paralysis on the rotator muscles of the shoulder. First of all, the investigators want to study the reproducibility of the isometric contraction forces of the rotator muscles of the shoulder thanks to an isokinetic dynamometer. The investigatorsthen want to compare the measurements obtained from the paralyzed side compared to the healthy side. The preoperative MRI performed will be studied in search of amyotrophy. These data will be compared with those of the isokinetic assessment to identify children requiring muscle transfer of reinforcement of the external rotator muscles.

NCT ID: NCT03440346 Completed - Clinical trials for Attention Deficit-Hyperactivity Disorder

Biomarker Research in ADHD: the Impact of Nutrition

BRAIN
Start date: February 19, 2018
Phase: N/A
Study type: Interventional

Attention deficit hyperactivity disorder (ADHD) is the most common childhood behavioural disorder, causing significant impediment to a child's development. The exact aetiology of ADHD is still unknown. It is a complex disorder with numerous contributing (epi)genetic and environmental factors. Currently, treatment predominantly consists of behavioural and pharmacological therapy. However, medication use is associated with several side effects and concerns about long-term effects and efficacy exist. Therefore, there is considerable interest in the development of alternative treatment options. Double-blind research investigating the effect of a few-foods diet (FFD) has demonstrated large improvements in ADHD symptoms. However, following an FFD requires great effort of both the child and parents. To make this treatment easier or potentially obsolete, it is important to understand how and in which children an FFD affects ADHD symptoms. The investigators hypothesise that an FFD affects brain function and behaviour, including ADHD symptoms, via the complex network of communication between the microbiota, gut and brain, i.e. the MGB axis. The aim of this study is to identify potential mechanism(s) underlying the impact of an FFD on ADHD symptoms and to identify biomarkers that predict the response to the FFD. 100 boys with ADHD will follow the FFD for 5 weeks. After inclusion, all participants will start with a baseline period, during which they will maintain their regular diet. The baseline period ends at the end of week 2. Thereafter, participants will follow a 5-week FFD, preceded by a 1-week transition period. The FFD period ends at the end of week 8. At the end of the baseline period (i.e. at the end of week 2) and at the end of the FFD (i.e. at the end of week 8), fMRI scans will be made, blood and buccal saliva will be collected, and stool and urine will be handed in. Children will do computer tasks and parents will complete questionnaires to monitor ADHD and physical complaints. All samples will be analysed by researchers blinded to behavioural responses to the FFD. To assess the impact of the FFD on brain function and the MGB axis, associations between ADHD behavioural changes and changes in other primary and secondary study outcomes will be analysed. This study may lead to the identification of biomarkers that can predict the response to an FFD. Understanding which changes - induced by an FFD - lead to improvements in ADHD symptoms may provide new avenues for developing treatments. Ultimately, the findings may enable personalised intervention strategies based on an individuals' configuration of the MGB axis.